An international research team revealed the atomic‐level structure of the human peptidase enzyme meprin β (beta).
Researchers have identified key molecular pathways which lead to late-onset Alzheimer's disease. The study presents a new approach to Alzheimer's research and highlights several potential drug targets.
Researchers reveal how two classes of drug compounds, which are currently in trial, work to fight Alzheimer's disease. They also identify possible causes of early onset hereditary forms of AD.
Researchers have identified and validated two rare gene mutations which could be a cause for late onset Alzheimer's disease.
A new study provides insight into the link between ApoE4 and SirT1, an anti-aging protein found is resveratrol.
Researchers use a novel genomic approach to better understand genetic mutations associated with familial Alzheimer's disease.
Pericytes could provide novel targets for the treatment and diagnosis of Alzheimer's disease, a new study reports.
Researchers report of creating two new mouse models of Alzheimer's disease. They believe the models could potentially revolutionize research into the neurodegenerative disease.
Researchers identify compounds that stabilize retromer protein complex and protects neurons from amyloid-beta.
In animal studies, researchers have identified a compound which reduces amyloid beta proteins by more than half.